Recombinant Human HDAC7A Protein，His

Histone deacetylases (HDACs) play crucial roles in regulating gene expression, protein function, and cellular processes by removing acetyl groups from histone and non-histone proteins. Among the 18 known HDACs, HDAC7A (also referred to as HDAC7) has garnered significant attention due to its involvement in various biological processes and diseases, including cancer, cardiovascular disorders, and inflammatory responses. HDAC7A is primarily localized in the nucleus and is known to interact with several transcription factors, influencing the expression of key genes involved in cell proliferation and survival. The study of HDAC7A, particularly through recombinant protein techniques, has provided insights into its enzymatic function, substrate specificity, and regulatory mechanisms. Research on HDAC7A has highlighted its dual role in both promoting and inhibiting transcription, depending on the context and associated cofactors. Furthermore, the aberrant expression or activity of HDAC7A has been linked to tumorigenesis, making it a potential therapeutic target. The generation of recombinant HDAC7A allows for the detailed characterization of its biochemical properties, the screening of small molecule inhibitors, and the exploration of its role in signal transduction pathways. Thus, understanding the function and regulation of HDAC7A is essential for developing targeted strategies in treating diseases where its dysregulation is implicated. The ongoing research aims to unravel the complexities of HDAC7A's role in cellular regulation and its potential as a target for therapeutic intervention.